Si-Bone (SIBN) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.79% |
| Dec 31, 2025 | 3.14% |
| Sep 30, 2025 | 1.05% |
| Jun 30, 2025 | 1.84% |
| Mar 31, 2025 | 0.18% |
| Dec 31, 2024 | 1.21% |
| Sep 30, 2024 | 0.15% |
| Jun 30, 2024 | -0.49% |
| Mar 31, 2024 | -2.27% |
| Dec 31, 2023 | -2.43% |
| Sep 30, 2023 | -2.15% |
| Jun 30, 2023 | 88.81% |
| Mar 31, 2023 | -4.42% |
| Dec 31, 2022 | -4.40% |
| Sep 30, 2022 | -7.22% |
| Jun 30, 2022 | -9.48% |
| Mar 31, 2022 | -8.91% |
| Dec 31, 2021 | -6.40% |
| Sep 30, 2021 | -6.86% |
| Jun 30, 2021 | -4.62% |
| Mar 31, 2021 | -4.54% |
| Dec 31, 2020 | 65.99% |
| Sep 30, 2020 | -5.41% |
| Jun 30, 2020 | -7.23% |
| Mar 31, 2020 | 84.53% |
| Dec 31, 2019 | -8.63% |
| Sep 30, 2019 | -11.30% |
| Jun 30, 2019 | -6.05% |
| Mar 31, 2019 | -8.25% |
| Dec 31, 2018 | 164.69% |
| Sep 30, 2018 | -2.75% |
| Jun 30, 2018 | -1.90% |
| Mar 31, 2018 | -2.93% |